204 related articles for article (PubMed ID: 25670515)
1. Pharmacogenetics of opioid response.
Somogyi AA; Coller JK; Barratt DT
Clin Pharmacol Ther; 2015 Feb; 97(2):125-7. PubMed ID: 25670515
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics of opioids.
Somogyi AA; Barratt DT; Coller JK
Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
[TBL] [Abstract][Full Text] [Related]
3. Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectives.
Lötsch J; Skarke C; Liefhold J; Geisslinger G
Clin Pharmacokinet; 2004; 43(14):983-1013. PubMed ID: 15530129
[TBL] [Abstract][Full Text] [Related]
4. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.
Zahari Z; Ismail R
Drug Metab Pharmacokinet; 2014; 29(1):29-43. PubMed ID: 23759977
[TBL] [Abstract][Full Text] [Related]
5. Trends in Tramadol: Pharmacology, Metabolism, and Misuse.
Miotto K; Cho AK; Khalil MA; Blanco K; Sasaki JD; Rawson R
Anesth Analg; 2017 Jan; 124(1):44-51. PubMed ID: 27861439
[TBL] [Abstract][Full Text] [Related]
6. Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management.
Jannetto PJ; Bratanow NC
Pharmacogenomics; 2009 Jul; 10(7):1157-67. PubMed ID: 19604091
[TBL] [Abstract][Full Text] [Related]
7. Reviewing pharmacogenetics to advance precision medicine for opioids.
Magarbeh L; Gorbovskaya I; Le Foll B; Jhirad R; Müller DJ
Biomed Pharmacother; 2021 Oct; 142():112060. PubMed ID: 34523422
[TBL] [Abstract][Full Text] [Related]
8. Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.
Solhaug V; Molden E
Scand J Pain; 2017 Oct; 17():193-200. PubMed ID: 29054049
[TBL] [Abstract][Full Text] [Related]
9. [Genetic polymorphisms and opioid therapies].
Landau R
Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763
[TBL] [Abstract][Full Text] [Related]
10. Modelling the pharmacokinetics of tramadol: on the difference between CYP2D6 extensive and poor metabolizers.
Di Patti F; Fanelli D; Pedersen RS; Giuliani C; Torricelli F
J Theor Biol; 2008 Oct; 254(3):568-74. PubMed ID: 18640130
[TBL] [Abstract][Full Text] [Related]
11. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
12. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of Postoperative Pain Management: A Review.
Aroke EN; Kittelsrud JM
AANA J; 2020 Jun; 88(3):229-236. PubMed ID: 32442101
[TBL] [Abstract][Full Text] [Related]
14. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.
Adegbola MA
Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302
[TBL] [Abstract][Full Text] [Related]
15. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
Reynolds KK; Ramey-Hartung B; Jortani SA
Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064
[TBL] [Abstract][Full Text] [Related]
16. Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice.
Matic M; de Wildt SN; Tibboel D; van Schaik RHN
Clin Chem; 2017 Jul; 63(7):1204-1213. PubMed ID: 28637770
[TBL] [Abstract][Full Text] [Related]
17. CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.
Smith DM; Weitzel KW; Elsey AR; Langaee T; Gong Y; Wake DT; Duong BQ; Hagen M; Harle CA; Mercado E; Nagoshi Y; Newsom K; Wright A; Rosenberg EI; Starostik P; Clare-Salzler MJ; Schmidt SO; Fillingim RB; Johnson JA; Cavallari LH
Genet Med; 2019 Aug; 21(8):1842-1850. PubMed ID: 30670877
[TBL] [Abstract][Full Text] [Related]
18. CYP2D6 in the metabolism of opioids for mild to moderate pain.
Leppert W
Pharmacology; 2011; 87(5-6):274-85. PubMed ID: 21494059
[TBL] [Abstract][Full Text] [Related]
19. Personalized therapy in pain management: where do we stand?
Stamer UM; Zhang L; Stüber F
Pharmacogenomics; 2010 Jun; 11(6):843-64. PubMed ID: 20504256
[TBL] [Abstract][Full Text] [Related]
20. The pharmacogenetics of codeine pain relief in the postpartum period.
Baber M; Chaudhry S; Kelly L; Ross C; Carleton B; Berger H; Koren G
Pharmacogenomics J; 2015 Oct; 15(5):430-5. PubMed ID: 25752520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
